HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcello Tonelli Selected Research

Pravastatin (Pravachol)

11/2006The effect of statins on preservation of kidney function in patients with coronary artery disease.
12/2005Effect of pravastatin in people with diabetes and chronic kidney disease.
7/2005Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
7/2005Biomarkers of inflammation and progression of chronic kidney disease.
9/2004Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
6/2003Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease.
1/2003Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcello Tonelli Research Topics

Disease

74Chronic Renal Insufficiency
04/2024 - 08/2002
57Chronic Kidney Failure (Chronic Renal Failure)
12/2021 - 01/2002
45Renal Insufficiency (Renal Failure)
04/2024 - 08/2002
29Proteinuria
11/2023 - 06/2003
29Kidney Diseases (Kidney Disease)
09/2023 - 06/2003
26Acute Kidney Injury (Acute Renal Failure)
04/2024 - 08/2002
23Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 06/2003
23Myocardial Infarction
07/2023 - 01/2003
21Albuminuria
11/2023 - 07/2006
19Stroke (Strokes)
10/2023 - 01/2003
16Hypertension (High Blood Pressure)
09/2023 - 09/2005
15Anemia
04/2024 - 04/2005
15Heart Failure
10/2023 - 03/2004
12Coronary Disease (Coronary Heart Disease)
10/2023 - 01/2003
10Inflammation (Inflammations)
10/2023 - 07/2005
9Neoplasms (Cancer)
04/2022 - 05/2009
7Infections
01/2021 - 04/2008
6Fistula
11/2023 - 01/2008
6Type 2 Diabetes Mellitus (MODY)
02/2023 - 11/2011
6Obesity
12/2022 - 10/2011
6Hemorrhage
07/2022 - 04/2007
5Acute Coronary Syndrome
01/2023 - 07/2005
5Thrombosis (Thrombus)
01/2023 - 01/2007
5Chronic Disease (Chronic Diseases)
11/2022 - 01/2014
5Bacteremia
01/2018 - 04/2008
4Atrial Fibrillation
10/2023 - 02/2015
4Nausea
09/2023 - 01/2013
4Transient Ischemic Attack
07/2023 - 06/2011
4Hyperkalemia
12/2021 - 04/2011
4Ambulatory Care Sensitive Conditions
01/2019 - 11/2008
4Diabetes Mellitus
02/2018 - 11/2004
4Hyperphosphatemia
05/2017 - 10/2005
4Malnutrition (Nutritional Deficiencies)
12/2015 - 09/2006
4Pathologic Constriction (Stenosis)
05/2012 - 11/2004
3Dementia (Dementias)
07/2023 - 08/2017
3Bone Diseases (Bone Disease)
01/2023 - 09/2004
3Ischemic Stroke
01/2023 - 06/2017
3Hypotension (Low Blood Pressure)
02/2020 - 09/2002
3Cognitive Dysfunction
10/2019 - 12/2015
3Hypercalcemia (Milk Alkali Syndrome)
11/2016 - 12/2009
3Arteriovenous Fistula
08/2013 - 01/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
11/2011 - 10/2004
2Glomerulonephritis
11/2023 - 07/2006
2Peripheral Arterial Disease
10/2023 - 09/2015

Drug/Important Bio-Agent (IBA)

52CreatinineIBA
04/2024 - 01/2003
21AlbuminsIBA
11/2023 - 02/2010
20Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 01/2003
15Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 08/2002
13Hemoglobins (Hemoglobin)IBA
01/2018 - 05/2006
11Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2006
9HematinicsIBA
01/2023 - 05/2009
9Angiotensin Receptor AntagonistsIBA
02/2020 - 08/2002
8Phosphates (Orthophosphate)IBA
05/2017 - 10/2005
7CholesterolIBA
01/2014 - 01/2003
7Pravastatin (Pravachol)FDA LinkGeneric
11/2006 - 01/2003
6MineralsIBA
01/2023 - 04/2005
5Insulin (Novolin)FDA Link
10/2023 - 09/2006
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2006
5LipidsIBA
06/2014 - 11/2004
4Dialysis SolutionsIBA
01/2023 - 09/2006
4HDL CholesterolIBA
01/2019 - 09/2004
4Biomarkers (Surrogate Marker)IBA
01/2019 - 07/2005
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2018 - 10/2004
4LDL CholesterolIBA
01/2018 - 09/2004
4Sevelamer (RenaGel)FDA Link
11/2016 - 09/2004
4oxidized low density lipoproteinIBA
07/2013 - 09/2006
3C-Reactive ProteinIBA
12/2022 - 01/2019
3insulin receptor-related receptor (IRR)IBA
01/2020 - 05/2012
3Parathyroid Hormone (Parathormone)IBA
01/2020 - 01/2013
3Alkaline PhosphataseIBA
11/2019 - 11/2009
3Triglycerides (Triacylglycerol)IBA
01/2019 - 11/2004
3Phosphorus (Red Phosphorus)IBA
11/2016 - 11/2013
3CalciumIBA
11/2016 - 05/2009
3Epoetin Alfa (Epogen)FDA Link
12/2014 - 10/2004
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2010 - 10/2004
3Vitamin DFDA LinkGeneric
11/2009 - 12/2007
3Oxidoreductases (Dehydrogenase)IBA
06/2006 - 01/2003
2continuous erythropoietin receptor activatorFDA Link
01/2023 - 12/2014
2epoetin betaIBA
01/2023 - 12/2014
2Estradiol (Delestrogen)FDA LinkGeneric
01/2023 - 11/2020
2MagnesiumIBA
01/2023 - 01/2020
2Darbepoetin alfa (Aranesp)FDA Link
01/2023 - 12/2014

Therapy/Procedure

57Renal Dialysis (Hemodialysis)
08/2023 - 09/2002
37Therapeutics
01/2024 - 11/2002
23Renal Replacement Therapy (Therapies, Renal Replacement)
04/2024 - 09/2004
17Kidney Transplantation
04/2024 - 11/2004
11Catheters
11/2023 - 01/2005
7Transplantation
04/2024 - 09/2007
7Peritoneal Dialysis
04/2024 - 09/2006
7Long-Term Care
07/2023 - 08/2017
5Central Venous Catheters
11/2023 - 09/2002
5Length of Stay
01/2023 - 02/2008
4Blood Transfusion (Blood Transfusions)
01/2023 - 05/2009
4Drug Therapy (Chemotherapy)
01/2021 - 10/2004
4Secondary Prevention
11/2019 - 01/2003
4Ambulatory Care (Outpatient Care)
11/2016 - 11/2008
4Glycemic Control
03/2013 - 05/2010
3Continuous Renal Replacement Therapy
07/2009 - 11/2002
2Surgical Amputation (Amputations)
02/2023 - 01/2021
2Conservative Treatment
01/2023 - 07/2013